Watson Laboratories, Inc. — Florida ("Watson") appeals from the decisions of the United States District Court for the District of Nevada (i) holding that the subject matter of the asserted claims of Ferring B.V.'s ("Ferring") U.S. Patents 7,947,739 (the "'739 patent"), 8,022,106 (the "'106 patent"), and 8,273,795 (the "'795 patent") would not have been obvious under 35 U.S.C. § 103, (ii) finding that Watson's generic tranexamic acid product infringed those claims...
Let's get started
Welcome to the leading source of independent legal reporting
Sign on now to see your case.
Or view more than 10 million decisions and orders.
- Updated daily.
- Uncompromising quality.
- Complete, Accurate, Current.